Cargando…
An enhancer RNA-based risk model for prediction of bladder cancer prognosis
BACKGROUND: Bladder cancer patients have a high recurrence and poor survival rates worldwide. Early diagnosis and intervention are the cornerstones for favorable prognosis. However, commonly used predictive tools cannot meet clinical needs because of their insufficient accuracy. METHODS: We have dev...
Autores principales: | Xu, Zhicheng, Xu, Chao, Wang, Qionghan, Ma, Shanjin, Li, Yu, Liu, Shaojie, Peng, Shiyuan, Tan, Jidong, Zhao, Xiaolong, Han, Donghui, Zhang, Keying, Yang, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515318/ https://www.ncbi.nlm.nih.gov/pubmed/36186809 http://dx.doi.org/10.3389/fmed.2022.979542 |
Ejemplares similares
-
Prognostic value and underlying mechanism of autophagy-related genes in bladder cancer
por: Peng, Shiyuan, et al.
Publicado: (2022) -
The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021) -
Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021) -
CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma
por: Liu, Shaojie, et al.
Publicado: (2021) -
CD248(+) Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma
por: Xu, Chao, et al.
Publicado: (2021)